Literature DB >> 27835739

Examining the association between attention deficit hyperactivity disorder and substance use disorders: A familial risk analysis.

Amy M Yule1, MaryKate Martelon2, Stephen V Faraone3, Nicholas Carrellas2, Timothy E Wilens4, Joseph Biederman4.   

Abstract

OBJECTIVE: The main aim of this study was to use familial risk analysis to examine the association between attention deficit hyperactivity disorder (ADHD) and substance use disorders (SUDs) attending to sex effects and the specificity of alcohol and drug use disorder risks.
METHODS: Subjects were derived from two longitudinal case-control family studies of probands aged 6-17 years with and without DSM-III-R ADHD of both sexes and their first degree relatives followed from childhood onto young adult years. Cox proportional hazard models were used to estimate rates of ADHD and SUDs (any SUD, alcohol dependence, and drug dependence). Logistic regression was used to test both co-segregation and assortative mating.
RESULTS: Our sample included 404 probands (ADHD: 112 boys and 96 girls; Control: 105 boys and 91 girls) and their 1336 relatives. SUDs in probands increased the risk for SUDs in relatives irrespective of ADHD status. The risk for dependence to drug or alcohol in relatives was non-specific. There was evidence that even in the absence of a SUD in the proband, ADHD by itself increased the risk of SUDs in relatives. Proband sex did not moderate the familial relationship between ADHD and SUDs. There was evidence of co-segregation between ADHD and SUD.
CONCLUSIONS: Findings indicate that various independent pathways are involved in the transmission of SUD in ADHD and that these risks were not moderated by proband sex. ADHD children and siblings should benefit from preventive and early intervention strategies to decrease their elevated risk for developing a SUD.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Attention deficit hyperactivity disorder; Co-segregation; Familial risk; Substance use disorder

Mesh:

Year:  2016        PMID: 27835739      PMCID: PMC5191927          DOI: 10.1016/j.jpsychires.2016.10.018

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  26 in total

1.  How persistent is ADHD? A controlled 10-year follow-up study of boys with ADHD.

Authors:  Joseph Biederman; Carter R Petty; Maggie Evans; Jacqueline Small; Stephen V Faraone
Journal:  Psychiatry Res       Date:  2010-05-30       Impact factor: 3.222

2.  The role of perceived need and health insurance in substance use treatment: implications for the Affordable Care Act.

Authors:  Mir M Ali; Judith L Teich; Ryan Mutter
Journal:  J Subst Abuse Treat       Date:  2015-02-23

3.  Psychiatric illness in the families of hyperactive children.

Authors:  D P Cantwell
Journal:  Arch Gen Psychiatry       Date:  1972-09

4.  Attention-deficit/hyperactivity disorder and risk for drug use disorder: a population-based follow-up and co-relative study.

Authors:  J Sundquist; H Ohlsson; K Sundquist; K S Kendler
Journal:  Psychol Med       Date:  2014-08-14       Impact factor: 7.723

Review 5.  Prospective association of childhood attention-deficit/hyperactivity disorder (ADHD) and substance use and abuse/dependence: a meta-analytic review.

Authors:  Steve S Lee; Kathryn L Humphreys; Kate Flory; Rebecca Liu; Kerrie Glass
Journal:  Clin Psychol Rev       Date:  2011-01-20

6.  Assessing cannabis use in adolescents and young adults: what do urine screen and parental report tell you?

Authors:  Martin Gignac; Timothy E Wilens; Joseph Biederman; A Kwon; E Mick; A Swezey
Journal:  J Child Adolesc Psychopharmacol       Date:  2005-10       Impact factor: 2.576

7.  Adult psychiatric outcomes of girls with attention deficit hyperactivity disorder: 11-year follow-up in a longitudinal case-control study.

Authors:  Joseph Biederman; Carter R Petty; Michael C Monuteaux; Ronna Fried; Deirdre Byrne; Tara Mirto; Thomas Spencer; Timothy E Wilens; Stephen V Faraone
Journal:  Am J Psychiatry       Date:  2010-01-15       Impact factor: 18.112

8.  Familial risk analysis of the association between attention-deficit/hyperactivity disorder and psychoactive substance use disorders.

Authors:  S Milberger; S V Faraone; J Biederman; M P Chu; T Wilens
Journal:  Arch Pediatr Adolesc Med       Date:  1998-10

9.  Familial transmission of substance use disorders.

Authors:  K R Merikangas; M Stolar; D E Stevens; J Goulet; M A Preisig; B Fenton; H Zhang; S S O'Malley; B J Rounsaville
Journal:  Arch Gen Psychiatry       Date:  1998-11

10.  Familial risk analysis of the association between attention-deficit/hyperactivity disorder and psychoactive substance use disorder in female adolescents: a controlled study.

Authors:  Joseph Biederman; Carter R Petty; Michael C Monuteaux; Eric Mick; Allison Clarke; Kristina Ten Haagen; Stephen V Faraone
Journal:  J Child Psychol Psychiatry       Date:  2009-03       Impact factor: 8.982

View more
  5 in total

1.  Does exposure to parental substance use disorders increase offspring risk for a substance use disorder? A longitudinal follow-up study into young adulthood.

Authors:  Amy M Yule; Timothy E Wilens; MaryKate Martelon; Lindsay Rosenthal; Joseph Biederman
Journal:  Drug Alcohol Depend       Date:  2018-03-10       Impact factor: 4.492

2.  Quantifying the Protective Effects of Stimulants on Functional Outcomes in Attention-Deficit/Hyperactivity Disorder: A Focus on Number Needed to Treat Statistic and Sex Effects.

Authors:  Joseph Biederman; Maura DiSalvo; Ronna Fried; K Yvonne Woodworth; Itai Biederman; Stephen V Faraone
Journal:  J Adolesc Health       Date:  2019-07-23       Impact factor: 5.012

3.  Translating Discoveries in Attention-Deficit/Hyperactivity Disorder Genomics to an Outpatient Child and Adolescent Psychiatric Cohort.

Authors:  Pieter J Vuijk; Joanna Martin; Ellen B Braaten; Giulio Genovese; Michael R Capawana; Sheila M O'Keefe; B Andi Lee; Hannah S Lind; Jordan W Smoller; Stephen V Faraone; Roy H Perlis; Alysa E Doyle
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2019-08-14       Impact factor: 8.829

4.  Effectiveness of Mindfulness-based Relapse Prevention on Quality of Life and Craving in Methadone-treated Patients: A Randomized Clinical Trial.

Authors:  Mehdi Yaghubi; Fatemeh Zargar
Journal:  Addict Health       Date:  2018-10

5.  Attention-Deficit/Hyperactivity Disorder Symptoms, Sensation-Seeking, and Sensory Modulation Dysfunction in Substance Use Disorder: A Cross Sectional Two-Group Comparative Study.

Authors:  Naama Assayag; Itai Berger; Shula Parush; Haim Mell; Tami Bar-Shalita
Journal:  Int J Environ Res Public Health       Date:  2022-02-22       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.